Patents by Inventor Srinivas Kodali

Srinivas Kodali has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RSV F protein mutants
    Patent number: 9950058
    Abstract: The present disclosure relates to RSV F protein mutants, nucleic acids or vectors encoding a RSV F protein mutant, compositions comprising a RSV F protein mutant or nucleic acid, and uses of the RSV F protein mutants, nucleic acids or vectors, and compositions.
    Type: Grant
    Filed: December 20, 2016
    Date of Patent: April 24, 2018
    Assignee: Pfizer Inc.
    Inventors: Ye Che, Philip Ralph Dormitzer, Alexey Vyacheslavovich Gribenko, Luke David Handke, Avvari Krishna Prasad, Xiayang Qiu, Mark Edward Ruppen, Xi Song, Kena Anne Swanson, Srinivas Kodali, Xin Xu, KariAnn Sweeney Efferen, Ping Cai, Kristin Rachael Tompkins, Lorna del Pilar Nunez
  • MANAGING COMMUNICATION NETWORKS AND COMPARING NETWORK TOPOLOGIES
    Publication number: 20170324621
    Abstract: In some implementations, a method includes obtaining a first visual representation of a first network topology of a network and a second visual representation of a second network topology. The first network topology includes a first set of network devices and a first set of connections between the first set of network devices. The second network topology includes a second set of network devices and a second set of connections between the second set of network devices. The method also includes alternating between presenting the first visual representation and presenting the second visual representation based on user input.
    Type: Application
    Filed: May 4, 2016
    Publication date: November 9, 2017
    Inventors: Robert Stephen Estes, Dieter Wolfgang Famula, Roma Bharat Bhansali, Sachin Saxena, Jacqueline A. Vasquez, Nikunj Desai, Domenico Zini, Steve Te Chiang, Srinivas Kodali
  • Saccharides and uses thereof
    Patent number: 9777076
    Abstract: The invention relates to novel saccharides and uses thereof. In one aspect, the invention relates to a saccharide having a legionaminic acid moiety, a N-acetylgalactosamine moiety, a galactose moiety, and a glucose moiety. In another aspect, the invention relates to a saccharide having an altruronic acid moiety, a fucose moiety, and a glucose moiety. In yet another aspect, the invention relates to a saccharide having a repeating unit of a glycerol phosphate moiety and a glucose moiety, wherein the saccharide is from Enterococcus faecium. In a further aspect, the invention relates to a saccharide having a repeating unit of -6-?-D-Fruf-2, wherein Fru is a fructose moiety, wherein the saccharide is from Enterococcus faecium. In another aspect, the invention relates to an isolated antibody or fragment thereof that specifically binds to a saccharide described herein and uses thereof.
    Type: Grant
    Filed: July 3, 2013
    Date of Patent: October 3, 2017
    Assignee: Pfizer Inc.
    Inventors: Robert G. K. Donald, Srinivas Kodali, Evguenii Vinogradov
  • RSV F Protein Mutants
    Publication number: 20170182151
    Abstract: The present disclosure relates to RSV F protein mutants, nucleic acids or vectors encoding a RSV F protein mutant, compositions comprising a RSV F protein mutant or nucleic acid, and uses of the RSV F protein mutants, nucleic acids or vectors, and compositions.
    Type: Application
    Filed: December 20, 2016
    Publication date: June 29, 2017
    Inventors: Ye Che, Philip Ralph Dormitzer, Alexey Vyacheslavovich Gribenko, Luke David Handke, Avvari Krishna Prasad, Xiayang Qiu, Mark Edward Ruppen, Xi Song, Kena Anne Swanson, Srinivas Kodali, Xin Xu, KariAnn Sweeney Efferen, Ping Cai, Kristin Rachael Tompkins, Lorna del Pilar Nunez
  • SACCHARIDES AND USES THEREOF
    Publication number: 20160002361
    Abstract: The invention relates to novel saccharides and uses thereof. In one aspect, the invention relates to a saccharide having a legionaminic acid moiety, a N-acetylgalactosamine moiety, a galactose moiety, and a glucose moiety. In another aspect, the invention relates to a saccharide having an altruronic acid moiety, a fucose moiety, and a glucose moiety. In yet another aspect, the invention relates to a saccharide having a repeating unit of a glycerol phosphate moiety and a glucose moiety, wherein the saccharide is from Enterococcus faecium. In a further aspect, the invention relates to a saccharide having a repeating unit of -6-?-D-Fruf-2, wherein Fru is a fructose moiety, wherein the saccharide is from Enterococcus faecium. In another aspect, the invention relates to an isolated antibody or fragment thereof that specifically binds to a saccharide described herein and uses thereof.
    Type: Application
    Filed: July 3, 2013
    Publication date: January 7, 2016
    Inventors: Robert G. K. Donald, Srinivas Kodali, Evguenii Vinogradov